Literature DB >> 24567377

Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection.

Suki M Y Lee1, Kin-Hang Kok, Martial Jaume, Timothy K W Cheung, Tsz-Fung Yip, Jimmy C C Lai, Yi Guan, Robert G Webster, Dong-Yan Jin, J S Malik Peiris.   

Abstract

Toll-like receptors (TLRs) play key roles in innate immune recognition of pathogen-associated molecular patterns of invading microbes. Among the 10 TLR family members identified in humans, TLR10 remains an orphan receptor without known agonist or function. TLR10 is a pseudogene in mice and mouse models are noninformative in this regard. Using influenza virus infection in primary human peripheral blood monocyte-derived macrophages and a human monocytic cell line, we now provide previously unidentified evidence that TLR10 plays a role in innate immune responses following viral infection. Influenza virus infection increased TLR10 expression and TLR10 contributed to innate immune sensing of viral infection leading to cytokine induction, including proinflammatory cytokines and interferons. TLR10 induction is more pronounced following infection with highly pathogenic avian influenza H5N1 virus compared with a low pathogenic H1N1 virus. Induction of TLR10 by virus infection requires active virus replication and de novo protein synthesis. Culture supernatants of virus-infected cells modestly up-regulate TLR10 expression in nonvirus-infected cells. Signaling via TLR10 was activated by the functional RNA-protein complex of influenza virus leading to robust induction of cytokine expression. Taken together, our findings identify TLR10 as an important innate immune sensor of viral infection and its role in innate immune defense and immunopathology following viral and bacterial pathogens deserves attention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24567377      PMCID: PMC3956146          DOI: 10.1073/pnas.1324266111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Recognition of microorganisms and activation of the immune response.

Authors:  Ruslan Medzhitov
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

2.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Authors:  C Y Cheung; L L M Poon; A S Lau; W Luk; Y L Lau; K F Shortridge; S Gordon; Y Guan; J S M Peiris
Journal:  Lancet       Date:  2002-12-07       Impact factor: 79.321

3.  Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88.

Authors:  Uzma Hasan; Claire Chaffois; Claude Gaillard; Virginie Saulnier; Estelle Merck; Sandra Tancredi; Chantal Guiet; Francine Brière; Jaromir Vlach; Serge Lebecque; Giorgio Trinchieri; Elizabeth E M Bates
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

4.  Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk.

Authors:  Xin-Xi Zhou; Wei-Hua Jia; Guo-Ping Shen; Hai-de Qin; Xing-Juan Yu; Li-Zhen Chen; Qi-Sheng Feng; Yin Yao Shugart; Yi-Xin Zeng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

5.  Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells.

Authors:  Ronan Le Goffic; Julien Pothlichet; Damien Vitour; Takashi Fujita; Eliane Meurs; Michel Chignard; Mustapha Si-Tahar
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

6.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

7.  Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination.

Authors:  Shohei Koyama; Ken J Ishii; Himanshu Kumar; Takeshi Tanimoto; Cevayir Coban; Satoshi Uematsu; Taro Kawai; Shizuo Akira
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

8.  TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples.

Authors:  Ross Lazarus; Benjamin A Raby; Christoph Lange; Edwin K Silverman; David J Kwiatkowski; Donata Vercelli; Walt J Klimecki; Fernando D Martinez; Scott T Weiss
Journal:  Am J Respir Crit Care Med       Date:  2004-06-16       Impact factor: 21.405

9.  Recognition of single-stranded RNA viruses by Toll-like receptor 7.

Authors:  Jennifer M Lund; Lena Alexopoulou; Ayuko Sato; Margaret Karow; Niels C Adams; Nicholas W Gale; Akiko Iwasaki; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

10.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.

Authors:  Menno D de Jong; Cameron P Simmons; Tran Tan Thanh; Vo Minh Hien; Gavin J D Smith; Tran Nguyen Bich Chau; Dang Minh Hoang; Nguyen Van Vinh Chau; Truong Huu Khanh; Vo Cong Dong; Phan Tu Qui; Bach Van Cam; Do Quang Ha; Yi Guan; J S Malik Peiris; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar
Journal:  Nat Med       Date:  2006-09-10       Impact factor: 53.440

View more
  64 in total

Review 1.  The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review.

Authors:  Maximiliano Javier Jiménez-Dalmaroni; M Eric Gerswhin; Iannis E Adamopoulos
Journal:  Autoimmun Rev       Date:  2015-08-20       Impact factor: 9.754

Review 2.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

Review 3.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

4.  TLR10 suppresses the activation and differentiation of monocytes with effects on DC-mediated adaptive immune responses.

Authors:  Nicholas J Hess; Christopher Felicelli; Jennifer Grage; Richard I Tapping
Journal:  J Leukoc Biol       Date:  2017-02-24       Impact factor: 4.962

5.  Toll-like Receptor 10 in Helicobacter pylori Infection.

Authors:  Hiroyuki Nagashima; Shun Iwatani; Modesto Cruz; José A Jiménez Abreu; Tomohisa Uchida; Varocha Mahachai; Ratha-Korn Vilaichone; David Y Graham; Yoshio Yamaoka
Journal:  J Infect Dis       Date:  2015-05-14       Impact factor: 5.226

Review 6.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

Review 7.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

Review 8.  An overview of the lagomorph immune system and its genetic diversity.

Authors:  Ana Pinheiro; Fabiana Neves; Ana Lemos de Matos; Joana Abrantes; Wessel van der Loo; Rose Mage; Pedro José Esteves
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

9.  Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?

Authors:  P Fernandes; J MacSharry; T Darby; A Fanning; F Shanahan; A Houston; E Brint
Journal:  Clin Exp Immunol       Date:  2015-11-26       Impact factor: 4.330

Review 10.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.